Larimar Therapeutics Company Insiders

Larimar Therapeutics Management Team Effectiveness

The company has return on total asset (ROA) of (0.2855) % which means that it has lost $0.2855 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.445) %, meaning that it created substantial loss on money invested by shareholders. Larimar Therapeutics' management efficiency ratios could be used to measure how well Larimar Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of 02/26/2025, Return On Tangible Assets is likely to drop to -0.47. In addition to that, Return On Capital Employed is likely to grow to -0.41. At this time, Larimar Therapeutics' Non Current Assets Total are relatively stable compared to the past year. As of 02/26/2025, Non Currrent Assets Other is likely to grow to about 795.7 K, while Other Current Assets are likely to drop slightly above 2.4 M. As of 02/26/2025, Common Stock Shares Outstanding is likely to grow to about 53 M, while Net Loss is likely to drop (42.7 M).

Larimar Therapeutics Workforce Comparison

Larimar Therapeutics Insider Trading History

Larimar Therapeutics Notable Stakeholders

The success or failure of an entity such as Larimar Therapeutics often depends on how effective the management is. Larimar Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Larimar management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Larimar management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running Larimar Therapeutics' price analysis, check to measure Larimar Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Larimar Therapeutics is operating at the current time. Most of Larimar Therapeutics' value examination focuses on studying past and present price action to predict the probability of Larimar Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Larimar Therapeutics' price. Additionally, you may evaluate how the addition of Larimar Therapeutics to your portfolios can decrease your overall portfolio volatility.